share_log

Mayfair Advisory Group LLC Purchases 2,245 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Mayfair Advisory Group LLC Purchases 2,245 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

梅费尔咨询集团有限责任公司收购了 DENTSPLY SIRONA Inc.(纳斯达克股票代码:XRAY)的2,245股股票
Financial News Live ·  2023/02/04 10:32

Mayfair Advisory Group LLC boosted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) by 28.3% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,190 shares of the medical instruments supplier's stock after purchasing an additional 2,245 shares during the period. Mayfair Advisory Group LLC's holdings in DENTSPLY SIRONA were worth $297,000 as of its most recent SEC filing.

根据梅菲尔咨询集团最近向美国证券交易委员会提交的13F文件,该公司在第三季度将其在DENTSPLY SIRONA Inc.(纳斯达克:XRAY-GET评级)的股票头寸提高了28.3%。该基金在此期间额外购买了2245股后,拥有这家医疗器械供应商的10190股股票。截至最近提交给美国证券交易委员会的文件,梅菲尔咨询集团持有的DENTSPLY SIRONA股份价值29.7,000美元。

Several other hedge funds also recently added to or reduced their stakes in the company. Macquarie Group Ltd. boosted its position in DENTSPLY SIRONA by 3.2% in the 2nd quarter. Macquarie Group Ltd. now owns 8,879 shares of the medical instruments supplier's stock valued at $318,000 after buying an additional 274 shares during the period. Park Avenue Securities LLC boosted its position in DENTSPLY SIRONA by 4.6% in the 2nd quarter. Park Avenue Securities LLC now owns 6,403 shares of the medical instruments supplier's stock valued at $229,000 after buying an additional 280 shares during the period. S&CO Inc. boosted its position in DENTSPLY SIRONA by 0.5% in the 2nd quarter. S&CO Inc. now owns 85,747 shares of the medical instruments supplier's stock valued at $3,063,000 after buying an additional 400 shares during the period. Mutual of America Capital Management LLC boosted its position in DENTSPLY SIRONA by 1.5% in the 3rd quarter. Mutual of America Capital Management LLC now owns 29,893 shares of the medical instruments supplier's stock valued at $847,000 after buying an additional 452 shares during the period. Finally, Diversified Trust Co boosted its position in DENTSPLY SIRONA by 2.5% in the 3rd quarter. Diversified Trust Co now owns 19,140 shares of the medical instruments supplier's stock valued at $543,000 after buying an additional 472 shares during the period. 98.52% of the stock is currently owned by institutional investors.

其他几家对冲基金最近也增持或减持了该公司的股份。麦格理集团(Macquarie Group Ltd.)第二季度将其在DENTSPLY SIRONA的头寸增加了3.2%。麦格理集团(Macquarie Group Ltd.)目前持有这家医疗器械供应商的8,879股股票,价值31.8万美元,在此期间又购买了274股。Park Avenue Securities LLC在第二季度将其在DENTSPLY SIRONA的头寸增加了4.6%。Park Avenue Securities LLC现在拥有这家医疗器械供应商6,403股股票,价值22.9万美元,在此期间又购买了280股。S&CO Inc.在第二季度将其在DENTSPLY SIRONA的头寸增加了0.5%。S&CO Inc.现在持有这家医疗器械供应商85,747股股票,价值3,063,000美元,在此期间又购买了400股。美国互惠资本管理有限责任公司在第三季度将其在DENTSPLY SIRONA的头寸增加了1.5%。美国互惠资本管理有限责任公司在此期间又购买了452股,现在拥有29,893股这家医疗器械供应商的股票,价值847,000美元。最后,多元化信托公司在第三季度将其在DENTSPLY SIRONA的头寸增加了2.5%。多元化信托公司现在拥有这家医疗器械供应商的19,140股票,价值543,000美元,在此期间又购买了472股。目前,该公司98.52%的股份由机构投资者持有。

Get
到达
DENTSPLY SIRONA
Dentsply SIRONA
alerts:
警报:

Wall Street Analyst Weigh In

华尔街分析师也加入进来

Several research firms have issued reports on XRAY. StockNews.com began coverage on shares of DENTSPLY SIRONA in a research report on Wednesday, October 12th. They issued a "hold" rating for the company. UBS Group lowered their price target on shares of DENTSPLY SIRONA to $35.00 in a research report on Thursday, November 17th. William Blair raised shares of DENTSPLY SIRONA from an "underperform" rating to a "market perform" rating in a research report on Wednesday, January 11th. Evercore ISI upped their price target on shares of DENTSPLY SIRONA to $34.00 in a research report on Thursday, November 17th. Finally, The Goldman Sachs Group lowered their price target on shares of DENTSPLY SIRONA from $41.00 to $34.00 and set a "neutral" rating for the company in a research report on Wednesday, November 16th. Seven equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat.com, DENTSPLY SIRONA presently has an average rating of "Hold" and an average target price of $40.70.

几家研究公司已经发布了关于X射线的报告。StockNews.com在10月12日星期三的一份研究报告中开始报道DENTSPLY SIRONA的股票。他们对该公司的评级为“持有”。瑞银集团在11月17日星期四的一份研究报告中将DENTSPLY SIRONA的股票目标价下调至35.00美元。在1月11日星期三的一份研究报告中,威廉·布莱尔将DENTSPLY SIRONA的股票评级从“表现不佳”上调至“市场表现”。在11月17日星期四的一份研究报告中,Evercore ISI将DENTSPLY SIRONA的股票目标价上调至34.00美元。最后,高盛夫妇在11月16日星期三的一份研究报告中将DENTSPLY SIRONA的股票目标价从41.00美元下调至34.00美元,并将该公司的评级定为“中性”。7名股票研究分析师对该股的评级为持有,3名分析师对该公司的评级为买入。根据MarketBeat.com的数据,DENTSPLY SIRONA目前的平均评级为持有,平均目标价为40.70美元。

DENTSPLY SIRONA Stock Performance

Dentsply SIRONA股票表现

DENTSPLY SIRONA stock traded down $1.22 during mid-day trading on Friday, reaching $38.44. 1,525,744 shares of the company traded hands, compared to its average volume of 1,820,563. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.50 and a quick ratio of 1.04. DENTSPLY SIRONA Inc. has a fifty-two week low of $26.48 and a fifty-two week high of $58.70. The company has a market capitalization of $8.26 billion, a price-to-earnings ratio of 14.04, a price-to-earnings-growth ratio of 5.42 and a beta of 0.94. The firm's fifty day moving average is $33.43 and its two-hundred day moving average is $32.57.
Dentsply SIRONA的股票在周五午盘交易中下跌1.22美元,至38.44美元。该公司1,525,744股易手,而其平均成交量为1,820,563股。该公司的债务权益比为0.48,流动比率为1.50,速动比率为1.04。Dentsply SIRONA Inc.的股价为26.48美元,为52周低点,52周高点为58.70美元。该公司市值为82.6亿美元,市盈率为14.04倍,市盈率为5.42倍,贝塔系数为0.94。该公司的50日移动均线切入位在33.43美元,200日移动均线切入位在32.57美元。

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last issued its quarterly earnings results on Monday, November 14th. The medical instruments supplier reported $0.41 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.59 by ($0.18). DENTSPLY SIRONA had a negative net margin of 20.81% and a positive return on equity of 9.63%. The company had revenue of $947.00 million for the quarter, compared to analyst estimates of $1.01 billion. During the same quarter in the previous year, the company posted $0.68 EPS. The company's revenue for the quarter was down 8.9% compared to the same quarter last year. On average, equities research analysts expect that DENTSPLY SIRONA Inc. will post 1.96 earnings per share for the current fiscal year.

Dentsply SIRONA(纳斯达克:XRAY-GET评级)上一次发布季度收益报告是在11月14日(星期一)。这家医疗器械供应商公布本季度每股收益(EPS)为0.41美元,低于分析师普遍预期的0.59美元(0.18美元)。Dentsply SIRONA的净利润率为负20.81%,股本回报率为正9.63%。该公司本季度营收为9.47亿美元,而分析师预期为10.1亿美元。去年同期,该公司公布的每股收益为0.68美元。与去年同期相比,该公司本季度的收入下降了8.9%。股票研究分析师平均预计,DENTSPLY SIRONA Inc.本财年每股收益将达到1.96美元。

DENTSPLY SIRONA Announces Dividend

Dentsply SIRONA宣布分红

The business also recently declared a quarterly dividend, which was paid on Friday, January 13th. Shareholders of record on Friday, December 30th were paid a dividend of $0.125 per share. The ex-dividend date of this dividend was Thursday, December 29th. This represents a $0.50 dividend on an annualized basis and a yield of 1.30%.

该公司最近还宣布了季度股息,股息于1月13日星期五支付。12月30日(星期五)登记在册的股东获得了每股0.125美元的股息。本次股息除息日期为12月29日星期四。这意味着年化股息为0.50美元,收益率为1.30%。

About DENTSPLY SIRONA

关于DENTSPLY SIRONA

(Get Rating)

(获取评级)

Dentsply Sirona, Inc engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products.

Dentsply Sirona,Inc.从事专业牙科产品和技术的设计、制造、销售和分销。它通过以下部分运作:技术和设备以及消耗品。技术和设备部门包括牙科技术、设备和医疗消耗品,如牙科植入物、实验室牙科产品、计算机辅助设计和计算机辅助制造系统、成像系统、治疗中心和消耗性医疗器械产品。

Featured Stories

专题报道

  • Get a free copy of the StockNews.com research report on DENTSPLY SIRONA (XRAY)
  • MarketBeat Week in Review – 1/30 – 2/3
  • Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
  • Zimmer Biomet Beats on Earnings, Growth May be Priced In
  • AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
  • Ford Stock Going Forward After Big Earnings Flop
  • 免费获取StockNews.com关于DENTSPLY SIRONA(XRAY)的研究报告
  • 市场回顾周-1/30-2/3
  • 细价股值得吗?你应该投资细价股吗?
  • Zimmer Biomet盈利节节攀升,增长可能被计入价格
  • 人工智能软件制造商EPAM号称科技板块涨幅最大
  • 福特股票在盈利大幅下滑后继续前进

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

接收DENTSPLY SIRONA日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对DENTSPLY SIRONA和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发